Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 22, 2026 16:10 ET | Source: C3is Inc.

C3is Inc. Announces the Acquisition of Two Medium Range Product Tankers

ATHENS, Greece, Jan. 22, 2026 (GLOBE NEWSWIRE) -- C3is Inc. (NASDAQ: CISS) (the “Company”), a ship-owning company providing dry bulk and tanker seaborne transportation services, announced today the...
January 22, 2026 16:10 ET | Source: Capital Clean Energy Carriers Corp.

Capital Clean Energy Carriers Corp. Declares Quarterly Dividend

ATHENS, Greece, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Capital Clean Energy Carriers Corp. (NASDAQ: CCEC) today announced that its board of directors has declared a cash dividend per share of $0.15 for...
January 22, 2026 16:10 ET | Source: Wintrust Financial Corporation

Wintrust Financial Corporation Announces Cash Dividends, Increasing Quarterly Common Stock Dividend Rate By 10%

ROSEMONT, Ill., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Wintrust Financial Corporation (“Wintrust” or the “Company”) (Nasdaq: WTFC) today announced that the Company’s Board of Directors approved a...
January 22, 2026 16:10 ET | Source: ASTERA LABS, INC.

Astera Labs Broadens Scorpio X-Series Smart Fabric Switch Roadmap to Address Expanding Scale-Up Market Opportunities

Astera Labs expands Scorpio X-Series Smart Fabric Switch roadmap with new features for $20 billion Merchant Scale-Up Switching Market
January 22, 2026 16:09 ET | Source: b1BANK

Business First Bancshares, Inc., Announces Financial Results for Fiscal Year 2025 and Q4 2025

BATON ROUGE, La., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Business First Bancshares, Inc. (NASDAQ: BFST) (Business First), parent company of b1BANK, today announced its unaudited results for the quarter...
January 22, 2026 16:05 ET | Source: Crinetics Pharmaceuticals, Inc.

Crinetics Initiates Phase 2/3 Pediatric Trial Evaluating Atumelnant in Congenital Adrenal Hyperplasia (CAH)

SAN DIEGO, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the first patient has been dosed in the BALANCE-CAH Phase 2/3 trial evaluating...
January 22, 2026 16:05 ET | Source: Peloton Interactive

Peloton Interactive, Inc. Announces Date of Second Quarter Fiscal 2026 Earnings Release and Conference Call

NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (NASDAQ: PTON) will release its second quarter fiscal 2026 financial results before the U.S. stock market opens on Thursday,...
January 22, 2026 16:05 ET | Source: Hub Group, Inc.

Hub Group Schedules Fourth Quarter 2025 Earnings Conference Call

OAK BROOK, Ill., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Hub Group, Inc. (Nasdaq: HUBG) will hold a conference call at 5:00 p.m. Eastern Time on Thursday, February 5, 2026, to discuss fourth quarter 2025...
January 22, 2026 16:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
January 22, 2026 16:05 ET | Source: Alpha Modus Corp.

Alpha Modus Announces Resolution of Patent Litigation with Mood Media

Alpha Modus announces resolution of patent litigation with Mood Media, with the case dismissed with prejudice and no claims remaining between the parties.